Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD171 (clone A1G0Z-A3). We employs the Lentivirus (SV40-BFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the Exons Inversion/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD171
Clone
A1G0Z-A3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
SV40
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.85
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.